OX2CRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。OX2遺伝子サイレンサーは、OX2 CRISPR/Cas9ノックアウトプラスミドとOX2Double Nickaseプラスミドとして利用可能です。遺伝子活性化用のOX2CRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
OX2 CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
OX2 CRISPR/Cas9 KOプラスミド (h) | sc-403573 | h | Gene Knockout | GFP | 0 | ||
OX2 HDRプラスミド (h) | sc-403573-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
OX2 Double Nickaseプラスミド (h) | sc-403573-NIC | h | Gene Knockout | Puromycin | 0 | ||
OX2 Double Nickaseプラスミド (h2) | sc-403573-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
OX2 CRISPR/Cas9 KOプラスミド (m) | sc-421696 | m | Gene Knockout | GFP | 0 | ||
OX2 HDRプラスミド (m) | sc-421696-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
OX2 Double Nickaseプラスミド (m) | sc-421696-NIC | m | Gene Knockout | Puromycin | 0 | ||
OX2 Double Nickaseプラスミド (m2) | sc-421696-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
OX2R CRISPR/Cas9 KOプラスミド (h) | sc-404121 | h | Gene Knockout | GFP | 0 | ||
OX2R HDRプラスミド (h) | sc-404121-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
OX2R Double Nickaseプラスミド (h) | sc-404121-NIC | h | Gene Knockout | Puromycin | 0 | ||
OX2R Double Nickaseプラスミド (h2) | sc-404121-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
OX2R CRISPR/Cas9 KOプラスミド (m) | sc-425439 | m | Gene Knockout | GFP | 0 | ||
OX2R HDRプラスミド (m) | sc-425439-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
OX2R Double Nickaseプラスミド (m) | sc-425439-NIC | m | Gene Knockout | Puromycin | 0 | ||
OX2R Double Nickaseプラスミド (m2) | sc-425439-NIC-2 | m | Gene Knockout | Puromycin | 0 |
OX2 CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
OX2 CRISPR Activationプラスミド (h) | sc-403573-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2 CRISPR Activationプラスミド (h2) | sc-403573-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2 Lentiviral Activation Particles (h) | sc-403573-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2 Lentiviral Activation Particles (h2) | sc-403573-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2 CRISPR Activationプラスミド (m) | sc-421696-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2 CRISPR Activationプラスミド (m2) | sc-421696-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2 Lentiviral Activation Particles (m) | sc-421696-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2 Lentiviral Activation Particles (m2) | sc-421696-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2R CRISPR Activationプラスミド (h) | sc-404121-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2R CRISPR Activationプラスミド (h2) | sc-404121-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2R Lentiviral Activation Particles (h) | sc-404121-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2R Lentiviral Activation Particles (h2) | sc-404121-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2R CRISPR Activationプラスミド (m) | sc-425439-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2R CRISPR Activationプラスミド (m2) | sc-425439-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2R Lentiviral Activation Particles (m) | sc-425439-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OX2R Lentiviral Activation Particles (m2) | sc-425439-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |